Integrated Advisors Network
IBB icon

Integrated Advisors Network’s iShares Biotechnology ETF IBB Stock Holding History

Integrated Advisors Network’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$321K Buy
1,525
+345
+29% +$69.2K 0.01% 540
2026
Q2 		$224K Sell
1,180
-1,015
-46% -$174K 0.01% 636
2026
Q1 		$371K Sell
2,195
-568
-21% -$97.1K 0.02% 515
2025
Q4 		$466K Buy
+2,763
New +$449K 0.02% 491
2024
Q4 		– Sell
-1,919
Closed -$279K – 730
2024
Q3 		$279K Sell
1,919
-450
-19% -$65.1K 0.01% 619
2024
Q2 		$325K Sell
2,369
-350
-13% -$46.7K 0.02% 547
2024
Q1 		$373K Buy
+2,719
New +$371K 0.02% 541
2023
Q3 		– Sell
-1,694
Closed -$215K – 681
2023
Q2 		$215K Buy
1,694
+1
+0.1% +$130 0.01% 619
2023
Q1 		$219K Sell
1,693
-4
-0.2% -$524 0.01% 611
2022
Q4 		$223K Sell
1,697
-188
-10% -$24.3K 0.01% 570
2022
Q3 		$220K Sell
1,885
-801
-30% -$99.5K 0.01% 576
2022
Q2 		$316K Buy
+2,686
New +$319K 0.02% 514
2022
Q1 		– Sell
-6,375
Closed -$973K – 681
2021
Q4 		$973K Sell
6,375
-720
-10% -$111K 0.06% 291
2021
Q3 		$1.15M Sell
7,095
-4,519
-39% -$760K 0.08% 234
2021
Q2 		$1.9M Buy
11,614
+1,813
+18% +$279K 0.14% 162
2021
Q1 		$1.48M Buy
9,801
+2,203
+29% +$350K 0.13% 164
2020
Q4 		$1.15M Buy
7,598
+279
+4% +$39.9K 0.13% 180
2020
Q3 		$991K Sell
7,319
-278
-4% -$37.7K 0.13% 179
2020
Q2 		$1.04M Sell
7,597
-373
-5% -$47.5K 0.12% 179
2020
Q1 		$859K Sell
7,970
-222
-3% -$25.6K 0.17% 145
2019
Q4 		$987K Buy
+8,192
New +$914K 0.13% 179

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Integrated Advisors Network's IBB Position: Q3 2026 in Review

Integrated Advisors Network increased its iShares Biotechnology ETF (IBB) stake by 29% in Q3 2026, buying an estimated $69.2K and bringing the position to 1,525 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #540.

Integrated Advisors Network first reported a position in IBB in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.9M in Q2 2021. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Integrated Advisors Network held 1,525 shares of iShares Biotechnology ETF worth $321K as of Q3 2026.
  • Integrated Advisors Network bought 345 iShares Biotechnology ETF shares in Q3 2026, an estimated $69.2K.
  • iShares Biotechnology ETF made up 0.01% of Integrated Advisors Network's portfolio in Q3 2026, its #540 holding.
  • Integrated Advisors Network first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 21 quarters since.
  • Integrated Advisors Network's iShares Biotechnology ETF position peaked at $1.9M in Q2 2021.
  • 700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.